Clinically Validated Synergy: Proprietary Dietary FiberBlends with Caloric Restriction Significantly Reduce Visceral Adipose Tissue inRandomized Controlled Trial

Title:  

Clinically Validated Synergy: Proprietary Dietary FiberBlends with Caloric Restriction Significantly Reduce Visceral Adipose Tissue inRandomized Controlled Trial  

Body:  

Blue Eyes Biotech Co., Ltd. presents breakthrough clinicalevidence from a 24-week RCT demonstrating our novel dietary fiber formulationssignificantly enhance visceral fat reduction when combined with caloricrestriction. In 120 overweight adults (BMI 28-35), our patented fiber-prebioticblend:  

✅ Reduced visceral adipose area (-15.2% vs-8.7% control, p<0.001) via CT scans  

✅ Amplified caloric restriction effects by74% for abdominal obesity  

✅ Improved metabolic biomarkers (HOMA-IR↓18.3%, adiponectin↑22.1%)  

Mechanistic Advantages for ProductDevelopers:  

1. Dual-Fiber Action: Soluble guar gum +insoluble oat β-glucan for enhanced satiety and SCFA production  

2. Prebiotic Synergy: FOS/GOS selectivelynourish Bifidobacterium spp. for butyrate synthesis  

3. Viscosity Optimization: Patentedhydration technology prolongs gastric emptying (T50↑ 40min)  

Application-Ready Solutions for:  

•WeightManagement Supplements: Clinically proven VAT reduction claims  

•FunctionalFoods: Clean-label fiber fortification (granules/powders)  

•PharmaceuticalExcipients: GRAS-certified sustained-release matrix  

Technical Superiority:  

- >85% fermentability (in vitro OECDmodel)  

- Neutral flavor/odor masking systems  

- Custom DP (Degree of Polymerization) 2-60for viscosity control  

Full-Service Partnership Includes:  

✓Clinical Trial Support: Protocol designto endpoint validation  

✓Custom Co-Processing: Withpolyphenols/probiotics for synbiotics  

✓Scale Flexibility: R&D samples to25MT batches (GMP/ISO22000)  

Request Clinical Dossier & FormulationGuides:  

[email protected]

Explore Fiber Innovations:www.blueeyes-bio.com